Screener
ImmunityBio, Inc. IBRX Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The source filing: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:37 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326110-26-000059
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 11) | ||
| Stockholders’ deficit: | ||
| Common Stock, $0.0001 par value; 1,650,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 1,047,341,146 and 1,011,800,008 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively; excluding treasury stock, 163,800 shares outstanding as of March 31, 2026 and December 31, 2025 | $104 | $101 |
| Additional paid-in capital | 3,461,865 | 3,197,120 |
| Accumulated deficit | (4,359,428) | (3,726,646) |
| Accumulated other comprehensive income | 27,453 | 28,956 |
| Total ImmunityBio stockholders’ deficit | (870,006) | (500,469) |
| Noncontrolling interests | 880 | 895 |
ITEM 1. FINANCIAL STATEMENTS.
FAQ
- What is ImmunityBio, Inc.'s common stock?
- ImmunityBio, Inc. (IBRX) reported common stock of 1.7B in Q1 2026.
- How has ImmunityBio, Inc.'s common stock changed year-over-year?
- ImmunityBio, Inc.'s common stock increased by 22.2% year-over-year, from 1.4B to 1.7B.
- What is the long-term trend for ImmunityBio, Inc.'s common stock?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s common stock has grown at a 746.3% compound annual growth rate (CAGR), from 38K to 1.7B.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about ImmunityBio, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude